跳至主要内容
临床试验/NCT06594406
NCT06594406已完成不适用

The Therapeutic Effects of Combining Bifidobacterium With Creatine on Depression

Zhujiang Hospital1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2024年10月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Change from Baseline in Hamilton Depression Rating Scale

研究概览

简要总结

The purpose of this clinical trial is to learn if Bifidobacterium has antidepressant-like effects by enhancing creatine absorption in adults. The main questions to be answered are

Does Bifidobacterium combined with creatine have better antidepressant effects? Does Bifidobacterium enhance exogenous creatine uptake?

Researchers will compare bifidobacterium combined with creatine with placebo to see if bifidobacterium combined with creatine has antidepressant effects.

Participants will:

Take bifidobacterium, creatine or placebo every day for 4 weeks. Keep a diary of their symptoms and collect blood samples.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •for depression:
  • •Adults age 18-60 years inclusive.
  • •Current diagnosis of major depression disorder (MDD) identified by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5 (SCID-5).
  • •Current Hamilton Depression Scale 17 score of >
  • •BMI (body Mass Index) between 18 and 28 kg/m²
  • •Right-handed

排除标准

  • •Diagnosis of bipolar disorder, schizophrenia, or schizoaffective disorder, identified by the SCID-
  • •History of or current diagnosis of acute kidney injury (AKI), chronic kidney disease (CKD) or end-stage renal disease (ESRD)
  • •History of seizure disorder
  • •Current serious suicide risk identified by the Columbia Severity Suicide Rating Scale
  • •Previous diagnosis of creatine deficiency syndrome or evidence of creatine deficiency syndrome
  • •Antibiotic use in last 30 days
  • •Probiotics use in last 30 days
  • •Positive pregnancy test
  • •Breastfeeding

研究组 & 干预措施

Healthy individuals with creatine and bifidobacterium

Experimental

干预措施: Bifidobacterium and creatine (Dietary Supplement)

Depression individuals with placebo

Placebo Comparator

Depressed individuals with placebo and antidepressants

干预措施: Placebo (Dietary Supplement)

Depression individuals with creatine and bifidobacterium

Experimental

Depression individuals with creatine and bifidobacterium and antidepressants

干预措施: Bifidobacterium and creatine (Dietary Supplement)

Healthy individuals with creatine

Experimental

干预措施: Creatine (Dietary Supplement)

结局指标

主要结局

Change from Baseline in Hamilton Depression Rating Scale

时间窗: 4 weeks

Comparison of Hamilton Depression Rating Scale before and after treatment

Change from Baseline in Hamilton Depression Rating Scale

时间窗: 4 weeks

Comparison of Hamilton Depression Rating Scale before and after treatment

次要结局

  • Change from baseline in creatine level in blood(4 weeks)
  • Change from baseline in creatine level in blood(4 weeks)

研究者

发起方
Zhujiang Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yan He

Professor

Zhujiang Hospital

研究点 (1)

Loading locations...

相似试验